Chapter 25 Ethnobotanical approach to pharmaceutical drug discovery: strengths and limitations

Advances in Phytomedicine

Volumn 1, Issue C, 2002, Pages 309-320

  Iwu, Maurice M ^a  

^a NONE

Author keywords

dereplication; ethnobotany; InterCEDD protocol; lead discovery

Indexed keywords

EID: 77957034159     PISSN: 1572557X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1572-557X(02)80034-4     Document Type: Chapter

References (24)

1. Baerheim Svendsen A. Biogene Arzneistoffe-heutte noch oder heute wieder?. In: Czygan F.-C. (Ed). Biogene Arzneistoffe Braunschweig: Freidr (1999), Vieweg and Sohns 27-39
2. Mueller H. Natural products and their importance in drug discovery. In: Luijendijk T., de Graf P., Remmelzwaal A., and Verporte R. (Eds). Years of natural products research: past, present and future (2000), University of Leiden, Leiden L05
3. Tyler V.E. The future of botanical drugs and the rainforest. J Herb Pharmacother 1 (2001) 5-12
4. Office of Technological Assessment. Pharmaceutical R&D: costs, risk and rewards (1993), OTA, Washington DC
5. Ch. 9. Drayer J.I., and Burns J.P. From discovery to the market: the development of pharmaceuticals. In: Wolff M.E. (Ed). Burger's medicinal chemistry and drug discovery. 5th edition (1995), Wiley, New York 257
6. DiMasi J.A., Hansen R.W., Grabowski H.G., and Lasagna L. J Health Econ 10 (1991) 107-142
7. Farnsworth N.R., and Bingel A.S. Problems and prospects of discovering new drugs from plants by pharmacological screening. In: Wagner H., and Wolf P. (Eds). New natural products and plant drugs with pharmacological, biological or therapeutical activity (1977), Springer, Berlin 1-22
8. CIBA Foundation. Ethnobotany and the search for new drugs, Symposium 185 (1994), Wiley, New York
9. Suffness M., and Douros J. Current status of the NCI Plant and Animal Products Program. J Nat Prod 45 (1982) 1-44
10. Cragg G.M., Boyd M.R., Cardellina J.H., Newman D.J., Snadder K.M., and McCloud T.G. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. CIBA Found Symp 185 (1994) 178-190
11. Cragg G.M., Newman D.J., and Snadder K.M.F. Natural products in drug discovery and development. J Nat Prod 60 (1997) 52-60
12. Dhar M., Dhar M.M., Dhawan B.N., Mehrotra B., and Ray C. Screening of Indian plants for biological activity 1. Indian J Exp Biol 6 (1968) 232-247
13. Dhawan B.N., Dubey M.F., Mehrotra B., Rastogi R.P., and Tandon S. Screening of Indian plants for biological activity 1. Indian J Exp Biol 18 (1980) 594-606
14. Fabricant D.S., and Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109 Suppl 1 (2001) 69-76
15. Ford R.I. The nature and status of ethnobotany. Anthropological Papers No. 67 (1978), University of Michigan, Introduction. Ann Arbor, MI 29-32
16. Alexiades MN, Sheldon JW, editors. (1992) Selected Guidelines for ethnobotanical research: a field manual.
17. Cardellina J.H., Fuller R.W., Gamble W.R., Westergaard C., Boswell J., Currens M., and Boyd M. Evolving strategies for the selection, dereplication and prioritization of antitumor and HIV-inhibitory natural products. In: Bohlin L., and Bruhn J.G. (Eds). Bioassay methods in natural product research and drug development, proceeding of the Phytochemical Society of Europe (1999), Kluwer Academic, Dordrecht 201
18. Cardellina J., Munro M.H.G., Fuller R.W., Manfredi K.P., McKee T.C., Tischler M., Bokesch H.R., Gustafson K.R., Beutler J.A., and Boyd M.R. A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products. J Nat Prod 56 (1993) 1123-1129
19. Cox P. The ethnobotanical approach to drug discovery: strengths and limitation. In: Prance G.T., Chadwick D.J., and Marsh J. (Eds). Ethnobotany and the search for new drugs. Ciba Foundation Symp 185 (1994), Wiley, New York 25-36
20. Cotton C.M. Ethnobotany: principles and application (1996), Wiley, Chichester, UK
21. Martin G. Ethnobotany, a methods manual (1995), Chapman & Hall, London 268
22. Cox P.A., and Balick M.J. The ethnobotanical approach to drug discovery. Sci Am 270 (1994) 60-65
23. Khafagi I.K., and Dewedar A. The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds. J Ethnopharmacol 71 (2000) 365-376
24. Schuster B.G., Jackson J.E., Obijiofor C.N., Okunji C.O., Milhous W., Losos E., Ayafor J.F., and Iwu M.M. Drug development and conservation of biodiversity in West and Central Africa: a model for collaboration with indigenous people. Pharm Biol 37 Suppl (1999) 1-16